Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nancy Simonian Insider Profile
4 Followers
Nancy Simonian, Director at Seagen, holds 135.66K shares in Syros Pharmaceuticals (Ticker: SYRS), holds 0.00 shares in Seagen (Ticker: SGEN), holds ― shares in Evelo Biosciences (Ticker: EVLO).
Nancy Simonian Seagen (SGEN)Director
Seagen (SGEN)
Director
Not Ranked
Nancy Simonian has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Nancy Simonian holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Nancy Simonian
Nancy Simonian's Trading History
Seagen
Dec 15, 2023
―
Uninformative Sell
14.37M
$0.00
Syros Pharmaceuticals
Jun 07, 2024
Director
Uninformative Buy
―
$268.60K
Evelo Biosciences
―
Director
―
―
Arqule
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Nancy Simonian's performance on stock
You May Also Like
Nancy Simonian insider profile FAQ
What is the percentage of profitable transactions made by Nancy Simonian?
The percentage of profitable transactions made by Nancy Simonian is ―.
What is the average return per transaction made by Nancy Simonian?
The average return per transaction made by Nancy Simonian is ―.
What stocks does Nancy Simonian hold?
Nancy Simonian holds: SGEN, SYRS, EVLO, ARQL stocks.
What was Nancy Simonian’s latest transaction?
Nancy Simonian latest transaction was an Uninformative Buy of ―.
What was Nancy Simonian's most profitable transaction?
Nancy Simonian’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Nancy Simonian's role in Seagen?
Nancy Simonian's role in Seagen is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.